ALG Health Revenue and Competitors
Estimated Revenue & Valuation
- ALG Health's estimated annual revenue is currently $3.3M per year.
- ALG Health's estimated revenue per employee is $251,000
Employee Data
- ALG Health has 13 Employees.
- ALG Health grew their employee count by -13% last year.
ALG Health's People
Name | Title | Email/Phone |
---|
ALG Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $487.4M | 1942 | 4% | N/A | N/A |
#2 | $16.3M | 65 | 0% | N/A | N/A |
#3 | $9.5M | 38 | 0% | N/A | N/A |
#4 | $4.3M | 17 | 13% | N/A | N/A |
#5 | $20.8M | 83 | -1% | N/A | N/A |
#6 | $85.3M | 340 | 8% | N/A | N/A |
#7 | $4M | 16 | 0% | N/A | N/A |
#8 | $165.2M | 658 | 0% | N/A | N/A |
#9 | $12.8M | 51 | 11% | N/A | N/A |
#10 | $10.8M | 43 | 34% | N/A | N/A |
What Is ALG Health?
Located in northwest Ohio, we manufacture N95 masks in America with globally-sourced materials. Masks are available for purchase by medical facilities/providers, wholesale accounts, retailers and consumers.
keywords:N/AN/A
Total Funding
13
Number of Employees
$3.3M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ALG Health News
2022-04-06 - KU Leuven drug discovery unit involved in development of ...
... novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has selected ALG-097558,...
2022-04-06 - Aligos Therapeutics Selects Drug Candidate ALG-097558, a ...
SARS-CoV-2 will remain a global health challenge, and despite the availability of effective vaccines, we still need potent and safe antiviral...
2022-03-30 - Early Outpatient Treatment for Covid-19 with Convalescent ...
... Brain Injury Outcomes Division (A.Y., K.L., N.A.M., A.L.G., N.K., ... S.E., S.N.B.), Johns Hopkins Bloomberg School of Public Health,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 13 | 550% | N/A |
#2 | $2M | 13 | 18% | N/A |
#3 | $1.3M | 15 | -17% | N/A |
#4 | $3.1M | 18 | 6% | N/A |
#5 | $2M | 20 | 100% | N/A |